Impax Laboratories competitors

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Nikhil Lalwani is a Board Member at ANI PHARMACEUTICALS INC and President/CEO at ANI PHARMACEUTICALS INC. He has worked as Chief Executive Officer at Cipla USA Inc.. Nikhil studied at Georgia Tech and The Wharton School.

José E. Almeida is a Brazilian businessman. He has served as the chairman and CEO of Baxter International, Inc. since January 2016. He worked for Tyco Healthcare from 1995 to 2002. He was president of Medical Devices division from October 2006 to June 2011. He served as chairman of the board of directors of Covidien since March 2012 and as the president, chief executive officer and a director since July 2011. He became a director of EMC Corporation on Jan 12, 2015 and resigned on October 30, 2015, due to his election as chairman and CEO of Baxter. In 2015, he worked for The Carlyle Group as an Operating Executive in the Global Healthcare group.

Dr. Caforio has been our Chief Executive Officer since May 2015. He was our Chief Executive Officer Designate from January to May 2015, our Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. He held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Hun School of Princeton and a member of the Business Roundtable, CEO Roundtable on Cancer and the Pharmaceutical Research and Manufacturers of America (PhRMA) and The Prium.

Timothy Crew is a Chief Executive Officer at LANNETT CO INC and Board Member at LANNETT CO INC. He has worked as VP:Alliances & Business Development at Teva Pharmaceutical Indus Ltd, Captain at United States Army, and CEO:North America at cipla. Timothy works or has worked at BRISTOL MYERS SQUIBB CO. He attended Columbia Graduate School of Business and Pomona.

Arpit Patel is an Associate Director, Quality Assurance and Compliance at Aurolife Pharma LLC and Chief Executive Officer & Board Member at CorePharma LLC and is based in Dayton, New Jersey. He has worked as Quality Engineer, Quality Compliance at 29 Consulting LLC - Vascular Therapies, Inc; Quality Assurance Consultant at CorePharma LLC; and Acting Director, Quality Assurance and Compliance at Aurolife Pharma LLC. Arpit attended Fairleigh Dickinson University-Metropolitan Campus between 2007 and 2009; Gujarat University, L M College of Pharmacy; and Telnet between 2002 and 2006.

Mr. Tabasso holds a B.A. from Cornell University, and a J.D. from Villanova University. Prior to joining KVK-Tech, Mr. Tabasso spent 16 years in private practice at a large Philadelphia law firm, where his practice focused on commercial litigation, business restructuring, and transactional work. After serving as outside counsel for many years, Mr. Tabasso joined KVK as President and CEO in August, 2013. Since that time, Mr. Tabasso’s focus has been on committing KVK to three core values: Regulatory Compliance, Safety, and Productivity. Mr. Tabasso has also dedicated KVK to strengthening its commitment to our customers and supply chain partners